SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop 10 kV silicon-carbide power devices is driving attention, with traders viewing it as technology validation and a potential opening in defense and infrastructure markets. The reaction is tempered by uncertainty over near-term revenue: the award is a prototype program with undisclosed financial terms, and some traders see the share move as a short-lived pop.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak surged after Zenkuda and KSI-501 met primary endpoints in the Phase 3 DAYBREAK trial for wet AMD. Traders celebrated the results and potential for differentiated treatments, while others questioned the drugs competitive edge and flagged the remaining FDA and commercialization hurdles, cash needs, and possible dilution.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas multibillion-dollar investment in Summit and clinical collaboration around ivonescimab are driving attention, with traders viewing the deal as a boost to funding and confidence in the cancer drug. The reaction is largely bullish, though some caution it is an equity investmentnot a buyoutand does not settle the drugs FDA outcome; short-squeeze and acquisition talk remains speculative.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs decision to let mortgage lenders use VantageScore is fueling concern that competition could weaken FICOs long-standing position and pricing power in mortgage scoring. Traders debate whether the selloff overstates the threat to a still-profitable, entrenched business, while bears also point to valuation and debt-funded buybacks as risks.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention centers on Helus Pharmas fully enrolled Phase 3 APPROACH trial of HLP003 for major depressive disorder, with topline results expected in Q4. Traders are positioning around the readout as a high-stakes catalyst, while debating the promise of earlier trial data against clinical uncertainty, possible dilution, and volatility.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

A sharp rally and reports of sizable buying have prompted speculation about a major investor or a potential deal, but neither a buyer nor a buyout is confirmed. Bullish traders also point to Recorlevs growth and XP-8121s Phase 3 progress, while skeptics note the drugs commercial potential remains years away.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs review of a 737 MAX software issue has delayed MAX 10 certification, prompting concern about delivery timing and Boeings quality record. Traders are divided over the setbacks significance, with some calling it a fixable, previously known issue and others viewing it as another sign of persistent execution problems.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

A sharp ZBCN rebound has fueled breakout chatter, with bullish traders pointing to improving chart action while skeptics warn the move may be a short-lived pump. Some also cite Zebecs payroll and payments partnerships as longer-term support, though speculation about additional deals remains unconfirmed.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs AI-data-center connectivity outlook is drawing attention after Fubon initiated coverage with a Buy rating, while traders debate whether the growth case justifies its valuation. The conversation also reflects sharp swings in the shares and broader semiconductor weakness, with bulls focused on AI infrastructure demand and bears warning of further pullbacks.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares are under pressure after its NEXT investor-day plan and outlook highlighted persistent inflation, sluggish restaurant traffic and substantial franchisee support and modernization spending; analyst price-target cuts have added to concerns about near-term growth and returns. Traders debate whether value, traffic and execution challenges point to further weakness or whether the steep selloff and oversold technicals create a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

McFarlane Lake Mining: Why Are Investors Watching Canada's Next Emerging Gold Developer?

McFarlane Lake Mining is advancing a multi-million-ounce gold resource in Ontario, its flagship property the “Juby Gold Project” continues its resource expansion, becoming one of the larger gold development projects in Canada's premier mining belt.
As investors continue seeking exposure to gold development projects in established mining jurisdictions, resource size, financial strength, and exploration upside remain key factors. McFarlane Lake Mining is focused on advancing its flagship Juby Gold Project in Ontario, which hosts a current mineral resource of approximately 6.2 million ounces of gold across the indicated and inferred categories.
Located between Sudbury and Timmins, two of Canada's most prolific mining camps, the project is undergoing continued drilling aimed at expanding the existing resource. The company recently achieved a significant balance sheet milestone by substantially reducing its outstanding debt, allowing more capital to be directed toward exploration and resource growth. Management believes the project has the potential to support a substantially larger gold inventory, the company’s internal target is to prove up 10 million ounces of gold and seeks to do this within a 2year time line.
With an established resource, active exploration program, strengthened capital structure, and multiple near-term catalysts, McFarlane Lake Mining is positioning itself as an emerging Canadian gold development company focused on creating long-term shareholder value.
For more information on McFarlane Lake Mining Limited (CSE: MLM), please click the request investor info button

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.read more...

Here's How Much You Would Have Made Owning Martin Marietta Materials Stock In The Last 15 Years

Martin Marietta Materials (NYSE:MLM) has outperformed the market over the past 15 years by 1.11% on an annualized basis producing an average annual return of 14.46%. Currently, Martin Marietta Materials has a marketread more...

Andvari Associates Strategic Investment in Martin Marietta Materials (MLM)

Andvari Associates Strategic Investment in Martin Marietta Materials (MLM...

Dycom Q2 Earnings & Revenues Top Estimates on Strong Fiber Demand

DY tops Q2 earnings and revenue estimates as fiber demand surges, while record backlog boosts visibility and fiscal 2027 revenue guidance rises.

Dycom to Report Q2 Earnings: Here's What to Expect This Season

DY's Q2 outlook points to strong AI and fiber demand, with surging backlog and revenue growth supporting another earnings beat.

Toll Brothers Beats Q3 Earnings & Revenue Estimates on Higher Pricing

TOL beats Q3 earnings and revenue estimates as higher home prices offset fewer deliveries, while orders grow despite margin pressure.

Will Martin Marietta's $13.5B Lhoist Deal Strengthen Long-Term Growth?

MLM's $13.5B Lhoist deal could expand its limestone platform and earnings base, but leverage and integration risks loom.

Can MLM Justify Its Premium Valuation as Earnings Growth Improves?

Martin Marietta's record aggregates shipments and raised 2026 revenue outlook support earnings growth, but its premium valuation raises the bar.

VMC Q2 Beat Keeps 2026 Outlook Intact Despite Higher Energy Costs

Vulcan beats Q2 estimates and holds its 2026 EBITDA outlook as pricing strength offsets energy inflation and weather pressure.

Martin Marietta Materials, Inc. is a natural resource-based building materials company, which engages in the provision of aggregates including crushed stone, sand, and gravel through its network of quarries and distribution yards. It operates through the East Group and West Group segments. The East Group segment offers aggregates and asphalt products. The West Group segment focuses on aggregates, cement, downstream products, and paving services. The company was founded on November 12, 1993 and is headquartered in Raleigh, NC.

Martin Marietta Materials, Inc.

Bearish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Current Price	$490.77
Prev Close	$484.30
Open	$481.04
Dividend Yield	0.52%
50-Day Moving Average	$527.33
Beta	0.85
Avg. Volume	553,533.49
PE Ratio	12.06

52-Week High	$710.97
52-Week Low	$476.82
Market Capitalization	$34.4B
EPS (Annual)	$18.76
Price to Book	2.55
Revenue Per Employee	$640,625.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MLM Fundamentals